Conformationally constrained o-tolylpiperazine camphorsulfonamide oxytocin antagonists. Structural modifications that provide high receptor affinity and suggest a bioactive conformation
- PMID: 7712132
- DOI: 10.1016/s0968-0896(00)82046-5
Conformationally constrained o-tolylpiperazine camphorsulfonamide oxytocin antagonists. Structural modifications that provide high receptor affinity and suggest a bioactive conformation
Abstract
A series of new o-tolylpiperazine camphorsulfonamide OT antagonists is described. Analogs containing conformationally constrained 1-acylamino-2-propyl substituents at the camphor C2 endo position exhibit high affinity for OT and AVP-V1a receptors or high affinity and selectivity for OT receptors, depending on functionalities present in the acyl group. Determination of the preferred conformation of potency-enhancing 1-acylamino-2-propyl substituents using molecular mechanics energy calculations and X-ray crystallography, along with topological similarities to a conformationally constrained cyclic hexapeptide OT antagonist, suggests a receptor-bound conformation for this series of non-peptide OT antagonists.
Similar articles
-
1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm labor.J Med Chem. 1994 Mar 4;37(5):565-71. doi: 10.1021/jm00031a004. J Med Chem. 1994. PMID: 8126695
-
Nanomolar-affinity, non-peptide oxytocin receptor antagonists.J Med Chem. 1993 Dec 10;36(25):3993-4005. doi: 10.1021/jm00077a002. J Med Chem. 1993. PMID: 8258821
-
Oral oxytocin antagonists.J Med Chem. 2010 Sep 23;53(18):6525-38. doi: 10.1021/jm901812z. J Med Chem. 2010. PMID: 20550119 No abstract available.
-
Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea.Adv Exp Med Biol. 1995;395:595-600. Adv Exp Med Biol. 1995. PMID: 8714023 Review.
-
Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.Prog Brain Res. 2008;170:473-512. doi: 10.1016/S0079-6123(08)00437-8. Prog Brain Res. 2008. PMID: 18655903 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous